On Sept. 1, renowned neurogeneticist Matthew Farrer, Ph.D., internationally recognized for his work on the genetics of Parkinson’s disease, will join UF Health, the University of Florida’s academic health center.
Farrer will be named an endowed chair of the Norman Fixel Institute for Neurological Diseases at UF Health in Parkinson’s disease research and will serve as a professor of neurology and director of the Clinical Genomics Program, part of the UF Clinical and Translational Science Institute.
“Dr. Farrer is a pioneer in Parkinson’s disease research. His talent and interests will synergize with ongoing efforts at UF to help us make significant progress in our fight to find novel interventions that help those suffering from devastating neurological disorders,” said MBI Executive Director Todd E. Golde, M.D., Ph.D.